Algo version: 0.98b
Shanghai Pharmaceuticals is listed at the PNK Exchange
Shanghai Pharmaceuticals [SHPMY]
PNK Sector: Healthcare Industry:Medical Distribution

Is Shanghai Pharmaceuticals stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Shanghai Pharmaceuticals pays dividends. Last time was Tuesday 12th of November 2024 where the investors holding the stock on Thursday 19th of September 2024 were paid $0.056 per share. Over the last 5 times between 2021 and 2024, Shanghai Pharmaceuticals has paid $1.441 with an average of $0.29 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Shanghai Pharmaceuticals 10 years ago, but if you had invested on Friday 22nd of November 2019 when the price was $9.11, you would have made a loss of $-1.230 per share or -13.50%

No, the average daily trading liquidity for Shanghai Pharmaceuticals is $2 380 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

Shanghai Pharmaceuticals has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a low cash flow to debt ratio of 0.09, the company's ability to pay off the debt is limited. The company has a very low net profit margin of 1.48%, which is challenging.

We have calculated the inflation risk for Shanghai Pharmaceuticals to be medium [0.65 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.